W hen oxygen delivery fails to meet tissue oxygen demand in critical illness, there is a compensatory increase in oxygen extraction. If the imbalance between oxygen delivery and consumption is uncorrected, the compensatory response is exhausted, resulting in an oxygen debt, global tissue hypoxia, anaerobic metabolism, and lactate production. Numerous studies have established the use of lactate as a diagnostic, therapeutic, and prognostic marker of global tissue hypoxia in circulatory shock (1) (2) (3) (4) (5) (6) . Blood lactate concentrations Ͼ4 mmol/L are unusual in normal and noncritically ill hospitalized patients, regardless of their underlying comorbidities (7) . Previous studies have shown that a lactate concentration Ͼ4 mmol/L in the presence of the systemic inflammatory response syndrome (SIRS) criteria significantly increases intensive care unit (ICU) admission rates and mortality rate in normotensive patients (8 -10) .
Persistent elevations in lactate Ͼ24 hrs are associated with mortality rate as high as 89% (11) . The sensitivity and specificity of single lactate concentrations as markers of tissue hypoperfusion have been debated (12) (13) (14) (15) ; however, serial measurements or lactate clearance over time may be better prognosticators of organ failure and mortality (16 -18) . Persistent elevated lactate Ͼ48 hrs in hemodynamically stable postoperative patients has been shown to be associated with an increased mortality rate (19) .
The emergency department (ED) is a portal for Ͼ108 million annual visits nationally, with 12% of ED visits resulting in hospital admission (20) . Approximately 51% of hospital admissions for severe sepsis require intensive care (21) . ED length of stay for the critically ill can range from 1 to 29 hrs before ICU admission, and recent trends in health care suggest that this duration is increasing (22) (23) (24) (25) . The unavoidable duration of stay frequently necessitates diagnostic and therapeutic interventions to attain hemodynamic stability that would otherwise be performed in the ICU. The ED is becoming an integral part of the chain of survival as it has been shown that the progression or resolution of organ dysfunction in critical illness is significant during the ED stay (26) . Furthermore, early goal-directed therapy in the most proximal stages of disease presentation has been shown to significantly decrease mortality rate in severe sepsis and septic shock (27) .
The purpose of this study was to examine the clinical utility of lactate clearance (or the percent decrease in lactate) as early as after 6 hrs as an indicator of multiple-system organ failure and death. We also define a lactate clearance cutoff that is associated with improved outcome after 6 hrs of ED intervention.
MATERIALS AND METHODS
Setting. The study was a prospective observational case series of adult patients enrolled over a 1-yr period and approved by the Institutional Review Board for Human Research at Henry Ford Hospital, Detroit. The study was conducted in an 850-bed urban tertiary care hospital with a 70-bed ED that provides care for approximately 86,000 patients per year. Critically ill patients are treated in a nine-bed intensive care area in the ED, equipped with hemodynamic monitoring and life support capabilities. This area is staffed by a boardcertified emergency physician, two emergency medicine residents, and five nurses, 24 hrs a day. Patients requiring further critical care are admitted to an ICU (medical, cardiac, neurologic, or surgical ICU) from this area.
Inclusion and Exclusion Criteria. Adult patients presenting to the ED with severe sepsis or septic shock (28) from February 1, 1999, to February 1, 2000, were enrolled after written informed consent within 1 hr of arrival (29) . Inclusion criteria consisted of a suspected sepsis source and the following: a) two of four SIRS (30) criteria (temperature Ͼ38°C or Ͻ36°C, heart rate Ͼ90 beats/min, respiratory rate Ͼ20 breaths/min, or PaCO 2 Ͻ32 mm Hg, or white blood cell count Ͼ12,000 cells per mm 3 , Ͻ4,000 cells per mm 3 , or Ͼ10% band cells) and a systolic blood pressure Ͻ90 mm Hg after a 20 mL/kg fluid challenge; or b) two of the SIRS criteria and an elevated lactate concentration (Ͼ4 mmol/L). Patients with an age Ͻ18 yrs, myocardial infarction, pulmonary edema, hemorrhagic shock, trauma, seizure, pregnancy, do-not-attempt-resuscitation orders, or requiring immediate surgery were excluded.
Patient Management. All patients received central venous and arterial catheterization in the ED and were managed according to the Society of Critical Care Medicine practice parameters for hemodynamic support of sepsis (31) . Volume resuscitation using crystalloids or colloids was initiated to achieve a central venous pressure of 8 -12 mm Hg. Vasoactive agents were used to maintain a mean arterial pressure Ͼ65 mm Hg. Urine output Ͼ0.5 mL·kg Ϫ1 ·hr Ϫ1 also served as a target goal. Patients were intubated and mechanically ventilated as required. All patients received evaluation by an intensive care specialist and were admitted to the ICU as soon as a bed became available.
Data Collection. The primary outcome variable was in-hospital mortality. Patient demographic information, admission diagnoses, and ED and hospital length of stay were recorded. Baseline vital signs (temperature, heart rate, mean arterial pressure), central venous pressure, arterial lactate, and laboratory values were obtained in the ED. Additional variables required to calculate the Acute Physiology and Chronic Health Evaluation (APACHE) II score (32) as an indicator of organ dysfunction were obtained at ED presentation (hour 0), hour 6, and during 72 hrs while in the hospital. Therapy given in the ED and up to 72 hrs in the hospital was recorded. Data were recorded on data forms and then entered in a database software (Paradox, Corel). The clinicians caring for the patients in the ED and in the hospital were blinded to the data collection process, and the study investigators did not influence clinical decision making.
Lactate Clearance Definition. Lactate clearance (percent) was defined using the following formula: lactate at ED presentation (hour 0) minus lactate at hour 6, divided by lactate at ED presentation, then multiplied by 100. A positive value denotes a decrease or clearance of lactate, whereas a negative value denotes an increase in lactate after 6 hrs of ED intervention.
Lactate clearance
Statistical Analysis. The Statistical Analysis System software (SAS Institute, Cary, NC) was used for data analysis. In-hospital mortality rate was determined by dividing the total number of deaths occurring in the hospital by the total number of patients enrolled in the study. Unless otherwise noted, data are presented as mean Ϯ SD. Statistical significance was defined as p Ͻ .05. Univariate in-hospital mortality comparisons (survivors vs. nonsurvivors) were made using either two-sample Student's t-tests or Wilcoxon rank sum tests for the continuous variables and either chisquare tests or Fisher's exact tests for the categorical variables. The variables with univariate comparison p Ͻ .05 were then included in a multivariate logistic regression analysis of in-hospital mortality rate. In addition, the sensitivity and specificity in predicting mortality of various lactate clearance cutoffs of Ϫ10, 0, 10, 20, 30, 40, and 50% were examined. Since there is no previous study defining lactate clearance as a percent decrease in lactate, we arbitrarily defined these cutoffs a priori. An optimal lactate clearance cutoff was defined as that lactate clearance with the maximum sum of sensitivity plus specificity for predicting in-hospital mortality. The various therapy and outcome measures of interest were then compared between the patients with lactate clearance below and above the cutoff. Kaplan-Meier estimation was used to obtain 60-day survival curves for lactate clearance below and above the cutoff, which were then compared using the log-rank test for survival data.
RESULTS
A total of 111 patients, 59 men and 52 women, were enrolled over a 1-yr period. The ED length of stay ranged from 1.5 to 17.6 hrs, which corresponded to 1.9% of the total hospital length of stay (range 6.8 hrs to 116.9 days). The predominant admission diagnoses were pneumonia and urosepsis, with 52.3% patients presenting in septic shock. Intubations were performed in the ED in 53.2% of patients requiring mechanical ventilation. Patients had a mean baseline APACHE II score of 20.2 Ϯ 6.8 and lactate of 6.9 Ϯ 4.6 mmol/L. The in-hospital mortality rate was 42.3% (Table 1) . Survivors compared with nonsurvivors had a lactate clearance of 38.1 Ϯ 34.6 vs. 12.0 Ϯ 51.6%, respectively (p ϭ .005) ( Table 2) .
Univariate comparisons of age, sepsis category, APACHE II score, vital signs, laboratory values, therapy given in the ED, and lactate clearance between survivors and nonsurvivors were performed (Table 2 ). There was a statistically significant difference between survivors and nonsurvivors for septic shock, platelet, prothrombin time, albumin, total bilirubin, lactate, and lactate clearance (all p Ͻ .05). Multivariate logistic regression modeling was then performed using the statistically significant univariate variables. Only lactate clearance was significantly associated with decreased mortality rate in the multivariate comparison (p ϭ .04) ( Table 3 ). There was an approximately 11% decrease in likelihood of mortality for each 10% increase in lactate clearance. Septic shock was not significantly associated with mortality rate in the multivariate comparison (p ϭ .07).
Analysis of lactate clearance cutoffs showed that a lactate clearance cutoff of Ͻ10% had the maximum sum of sensitivity plus specificity for predicting inhospital mortality. After 6 hrs of intervention, a lactate clearance of Ͻ10% had a sensitivity of 44.7%, specificity of 84.4%, and accuracy of 67.6% for predicting in-hospital mortality. Patients were then categorized as being in the lowclearance group (Ͻ10% clearance) or high-clearance group (Ն10% clearance) ( Table 4) . Both groups had similar characteristics such as age, vital signs, and laboratory values. However, the highclearance group had higher platelet counts and lower prothrombin times compared with the low-clearance group (p Ͻ .05). The high-clearance group received significantly less vasopressor therapy in the first 6 hrs compared with the low-clearance group (p ϭ .02) and continued to do so in the ICU (p ϭ .04). Both low-clearance and high-clearance groups had similar baseline APACHE II scores; however, the high-clearance group had lower score at 6 hrs and throughout the 72-hr study period (p Ͻ .05 at hours 12, 24, and 36). The high-clearance group had a 52.0% relatively lower in-hospital mortality rate compared with the lowclearance group (p Ͻ .001), and this mortality difference was similarly observed up to 60 days (Table 4 and Fig. 1) .
There were significantly more severe sepsis patients with high lactate clearance compared with patients with low lactate clearance (p ϭ .01; Table 4 ). In severe sepsis patients, those with high lactate clearance had significantly lower mortality rate than patients with low clearance (p ϭ .03). There were significantly fewer septic shock patients with high lactate clearance; however, there was a trend toward decreased mortality rate in these patients compared with the septic shock patients with low lactate clearance (p ϭ .01 and .06, respectively).
DISCUSSION
The pathogenic link between global tissue hypoxia, morbidity, and mortality in sepsis has been thoroughly documented. Although the mechanisms are complex, global tissue hypoxia that accompanies severe sepsis and septic shock independently contributes to the systemic inflammatory response leading to endothelial activation (33, 34) , vasodilation (35) , release of inflammatory mediators (36) , and modulation of the coagulation system (37, 38) , all resulting in the multiple organ dysfunction syndrome (39) and death. As a compensatory mechanism to the hemodynamic derangements in severe sepsis and septic shock, a surge in catecholamines and neural regulation maintains arterial pressure at the expense of decreased tissue perfusion. This renders vital signs poor resuscitation end points, prognosticators of outcome, and indicators of the degree of global tissue hypoxia in patients presenting with shock (40, 41) . Lactate represents a useful and clinically obtainable surrogate marker of tissue hypoxia and disease severity, independent of blood pressure (42) . Persistently elevated lactate has been shown to be better than oxygen transport variables (oxygen delivery, oxygen consumption, and oxygen extraction ratio) as an indicator of mortality rate. Among septic shock patients, only survivors had a significant decrease in lactate concentrations over the course of the disease. In contrast, nonsurvivors had significantly higher lactate concentrations during both the initial and final phases of shock (43). The interpretation of single lactate measurements has several limitations. First, blood lactate concentrations reflect the interaction between the production and elimination of lactate. For example, a sepsis patient with hepatic dysfunction may have a higher lactate compared with the patient without liver disease but may have a similar degree of stress. Second, an increased lactate concentration may indicate mechanisms other than cellular hypoxia, such as up-regulation in epinephrine-stimulated Na/K-adenosine triphosphatase activity in skeletal muscle (12) and inhibition of pyruvate metabolism or an increase in its production (15, 44, 45) . Given these limitations, serial lactate measurements are more important as an outcome prognosticator than a single lactate measurement (16 -18, 46) . Bakker et al. (16) defined "lactime" as the time during which lactate remains Ͼ2 mmol/L and observed that this duration of lactic acidosis was predictive of organ failure and survival. Trauma patients whose lactate normalized in 24 hrs (or lactime Յ24 hrs) were shown to have 100% survival (17) , whereas persistent lactate elevation Ͼ6 hrs is associated with increased mortality rate (47) . Additionally, elevated lactate concentrations up to 48 hrs are associated with higher mortality rate in postoperative hemodynamically stable patients (19) . A goal of resuscitation is then to minimize lactime.
The present study extends the concept of lactate normalization during early therapeutic intervention. Our findings suggest that lactate clearance, as defined by the percentage of lactate cleared over the first 6-hr period of disease presentation, is an independent variable associated with decreased mortality rate. Patients with high lactate clearance required less vasopressor therapy, had greater improvements in APACHE II scores, and had decreased mortality rates. During resuscitation, a lactate clearance of Ͼ10% from its baseline value in as brief a period as 6 hrs is achievable. When this clearance occurs during the most proximal stages of disease presentation such as the ED stay, it may be associated with improved organ function (decreased APACHE II score) and suggests decreased mortality rate up to 60 days. Our results also suggest that high lactate clearance is associated with decreased mortality rate in severe sepsis patients with elevated baseline lactate but without hypotension. This observation that organ hypoperfusion can exist in the presence of normotension further supports the notion that blood pressure is a poor indicator of disease severity.
Current methodologies using ICUbased physiologic scoring systems, such as APACHE II, have limited diagnostic and therapeutic application in the ED setting since those systems were designed to prognosticate outcome after the initial 24 hrs of ICU care (32, 48) . In this study, we calculated APACHE II in a nontraditional manner at discrete time points over the first 72 hrs to serially follow the trend in scores as an indicator of the progression of disease (26) . The addition of lactate clearance in assessing the patient's physiological reserve and as an indicator of outcome has further implications in understanding the progression of sepsis to multiple organ failure and death in the pre-ICU period. This study was limited to one urban ED setting with a high level of patient acuity and an ICU admission rate that nearly doubles the national average (49) . Therefore, the stratification of patients into lactate clearance groups with the observed mortality rates should be generalized only with caution to other EDs. Traditional resuscitation end points such as vital signs fail to definitively address the severity of global tissue hypoxia and thus are a poor reflection of the resuscitation and the development of organ failure and death. Initial serial lactate measurements in the presence of SIRS alert the clinician to the severity of illness and may be associated with outcome.
CONCLUSIONS
Lactate clearance in the most proximal presentation of severe sepsis and septic shock is associated with improved morbidity and mortality rates. This is consistent with current efforts that emphasize the importance of identifying and treating tissue hypoperfusion during the first 6 hrs of resuscitation (50) . Further clinical trials are needed to conclusively establish lactate clearance as a resuscitation end point and an outcome measure to be targeted during the most proximal phases of severe sepsis and septic shock. Kaplan-Meier survival analysis between patients with lactate clearance Ͻ10 vs. Ն10% at 6 hrs after emergency department presentation.
